Skip to content

The effectiveness of a sports program on fatigue and QoL in IBD patients with quiescent disease

The effectiveness of a sports program on fatigue and QoL in IBD patients with quiescent disease - Sports and IBD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44410
Enrollment
20
Registered
2017-11-30
Start date
2018-03-13
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease/IBD/Crohn's disease and Ulcerative colitis

Interventions

None listed

Sponsors

Rijnstate Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - The diagnosis of IBD must be based on a combination of clinical, endoscopic, histologic and radiologic internationally accepted criteria in the past. - Both patients with Crohn*s disease, Ulcerative colitis and IBD-unclassified in remission (SES-CD 0-2 and Mayo score 0). - The faecal calprotectin must be below 50. - Fatigue level on the Checklist Individual Strenght fatigue must be above or equal to 35 (CIS-F score *35) - Stable medication for at least 4 weeks before the screening visit. - Patients must be able and willing to provide written informed consent. - Patients between the age of 25 and 60 years, both men and women.

Exclusion criteria

Exclusion criteria: - IBD diagnosis within one year before the screening visit. - Intensive sport activities more than once a week in the past year. - Operation within 6 months before or 3 months after the screening visit - Coexistent chronic diseases for example heart failure, COPD an malignancies. - Pregnant at the moment of the screening visit or planning pregnancy within 3 months after the screening. - Participation in another medical research.

Design outcomes

Secondary

MeasureTime frame
Physical fitness including cardiorespiratory fitness, muscle strength and body composition.

Primary

MeasureTime frame
Change in fatigue complaints measured with the CIS-F checklist and in quality of life measured with the IBD-Q checklist.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)